Self-Funded Health Reserving News.
Self-funded health IBNR turns over fast, but the cost drivers behind it do not: GLP-1 coverage, stop-loss pricing, PBM rules, and federal mandates. This feed tracks the developments that change what benefits CFOs should accrue.
New to reserving this line? Start with IBNR for Self-Funded Health Plans.
DOL's Final PBM Rule Resets Self-Funded Rx Reserves
The Department of Labor finalized a rule on October 29, 2026 forcing PBMs to disclose rebates, spread pricing, and recoupments, with annual audit rights starting plan years on or after July 1, 2027, a cadence that will test whether current Rx IBNR assumptions match real rebate retention.
WTW's 11.1% Health Cost Trend Pressures Stop-Loss ECRs
WTW's 30th annual employer healthcare survey puts 2027 trend at 11.1% and names high-cost claimant frequency, not pharmacy unit price, as the lead driver, a distinction that matters more than the headline number for how carriers set the aggregate stop-loss corridor.
New York's PBM Pay-Floor Bill Awaits Signature, Costs Loom
New York's legislature passed a bill forcing PBMs to reimburse pharmacies at acquisition cost plus a Medicaid-level dispensing fee, and it is headed to Governor Hochul. For self-funded plans with New York enrollees, the mandate is a severity shock that lands mid-triangle, breaking completion factors in the renewal transition year rather than showing up as a gradual trend.
Lockton: Stop-Loss Renewals Could Hit 30% for 2027
Lockton's Q3 2026 market update puts 2027 stop-loss renewal increases at up to 30%, but the reserve story is not the premium: carriers are repricing attachments on less current data, which means self-funded plans holding deductibles flat are quietly retaining more severity than their IBNR assumes.
Fairview's $84M Verdict Tests Hospitals in No-Cap States
A Hennepin County jury awarded $84 million against Fairview Health Services, with $62.5 million of it for future loss of companionship alone, in a case where both sides largely agreed on the standard of care. For self-insured hospitals in states without non-economic damage caps, the verdict is a stress test of how case reserves and severity trends treat the non-economic component of hospital professional liability.
Oregon's Fake 'Self-Funded' Health Plan Warning Is a Buyer Checklist
Oregon's Division of Financial Regulation warned on September 22 that sham 'limited partner' health plans are borrowing the vocabulary of legitimate self-funding, including the word 'stop-loss,' to sell coverage with no actuarial reserve behind it. For benefits CFOs, the warning doubles as a diligence template: a real self-funded plan can show you its IBNR methodology, its named stop-loss carrier, and its filing history; a shell cannot.
CVS Caremark's Zepbound Return Splits GLP-1 Reserve Risk
CVS Caremark put Zepbound back on its standard commercial formulary October 1, 2026, the same month PepsiCo's PBM told employees weight-loss drug coverage is ending. Self-insured sponsors now sit on one of two opposite defaults into 2027, and a single GLP-1 trend assumption no longer describes either branch; each one changes the pharmacy expected claim ratio, and the stop-loss attachment, in a different direction.
Scentsy Ruling Makes Late Stop-Loss Claims a Reserve Issue
A September 3 Idaho federal ruling found a plan administrator breached its ERISA fiduciary duty after a high-cost infant claim missed a disputed stop-loss payment window. The reserve lesson is to carry the claim gross until the recovery is confirmed, rather than netting it because the care occurred in the policy period.
Employer Health Trend at 9.2% Puts Aggregate Stop-Loss at Risk
Two independent employer benefit surveys released this week both project 2027 health cost trend above 9%, the highest sustained reading in more than 20 years. For self-insured plans renewing stop-loss coverage this fall, the timing is acute: aggregate attachments priced on 5-6% trend assumptions carry a specific, calculable unhedged gap that cannot be corrected once open enrollment closes.
AI Claims Software Adds a Full Point to 2027 Health Plan Costs
Mercer's August 31 survey isolates AI-enabled physician billing as a new, quantified one-point driver of 2027 health benefit cost growth -- one that does not appear in any development triangle built from pre-2024 professional services data, understating the base on which every forward trend is applied.
DOL Retreats From ERISA; Plaintiff Class Actions Fill the Gap
The DOL's April 2026 enforcement pivot narrows regulatory risk for employer health plans but transfers it intact to plaintiff class action counsel. Self-funded plan sponsors that relax fiduciary documentation in response are increasing, not decreasing, their expected ERISA litigation cost.
Caterpillar ERISA Suit Extends Financial Dominance Theory
Three 2026 class actions, including Beyers v. Caterpillar covering 63,000-plus participants, argue that offering a mathematically inferior plan option violates ERISA fiduciary duty, creating a contingent employer liability that standard claims-based IBNR does not model.
Health Plan IDR Rulings Add $5B to Costs, Skewing IBNR Models
The No Surprises Act's arbitration process has added an estimated $5 billion to U.S. health system costs since 2022, with providers winning 88 percent of disputes; self-insured plan sponsors relying on pre-2022 paid triangles are systematically understating both expected claim ratios and development tails on recent accident years.
New Hampshire Sets Stop-Loss Floor at 110% of Expected Claims
New Hampshire's Bulletin INS 26-051-AB requires aggregate stop-loss attachment points for large employer groups at a minimum of 110% of actuarially supported expected claims, with annual carrier certification. The hidden risk is that a carrier using a below-market trend assumption satisfies the floor on paper while leaving the employer exposed in a silent corridor above the stated aggregate.
Sun Life: $3M-Plus Health Claims Up 47%, Aggregate at Risk
Sun Life's 2025 high-cost claim report shows the $3 million-plus tier of self-insured plan losses growing at nearly triple the rate of all million-dollar claims, exposing aggregate stop-loss corridors set on overall plan trend as structurally too narrow.
Why July's 2% Medical CPI Understates Health Plan IBNR Trend
The BLS July 2026 CPI shows medical care up 2% year over year; employer health plan cost trend surveys peg 2026 at 7-9%. The gap is structural, and anchoring IBNR to CPI systematically understates unpaid claim liability.
Stop-Loss Lasering Leaves Self-Insureds With Unhedged IBNR
When a stop-loss carrier raises an individual claimant's attachment point at renewal, the plan sponsor absorbs the difference. That retained exposure rarely appears in the next actuarial IBNR estimate.
Segal Q3 2026: Stop-Loss $1M Claims Growing 25 Percent per Year
Segal's Q3 2026 survey of 225 self-funded health plans finds seven-figure claimants growing at a 25 percent compound annual rate since 2022, a frequency shift that has outpaced stop-loss premium increases of 12.7 percent and left fixed attachment points retaining significantly more risk than their actuarial basis assumed.
Cardiovascular Claims Hit No. 2 in Stop-Loss as Costs Surge
Sun Life's 2026 high-cost claims report elevates cardiovascular disease to the second-highest stop-loss category as million-dollar claims rise 46%, forcing self-funded plans to revisit the frequency assumptions embedded in stop-loss IBNR.
Stop-Loss Reinsurance at 15% Signals a Multi-Year Rate Floor
Segal's Q3 2026 benchmarking report, drawing on 225 health plans, shows average stop-loss premiums up 12.7%, but the structural driver is a reinsurance correction cycle that carriers project will take three to five years to close, not one.
Medicaid Work Rule Took Effect July 31, Resetting Plan Frequency
The CMS interim final rule implementing Medicaid community engagement requirements became effective July 31, placing a January 1, 2027 state implementation deadline squarely inside the 2027 renewal window for self-insured health plans.
DOL MHPAEA Crackdown: Every Self-Funded Plan Initially Fails
DOL enforcement of mental health parity rules is producing a 100% initial failure rate on comparative analyses reviewed, creating a retroactive benefit liability that standard IBNR development cannot detect.
PwC Sets 2027 Medical Cost Trend at 9%, a 17-Year High
PwC's Behind the Numbers pegs the 2027 group medical trend at 9%, the highest since 2010. For a self-funded plan, trend is the dominant input to IBNR, so a plan still carrying 6% or 7% is already under-accrued, not just under-budgeted.
Segal: Stop-Loss Premiums Jump 13% as Leverage Bites
Segal's 2026 dataset shows specific stop-loss premiums up 12.7% for plans holding deductibles flat. The driver is leveraged trend: a fixed attachment point makes the reimbursed layer grow far faster than gross medical trend.
FTC Caremark Settlement Resets Self-Insured Rx Trend
The FTC's July 14 consent settlement with CVS Caremark restructures rebate flow and point-of-sale pricing across all drugs, resetting the net pharmacy trend and the rebate accrual lag that quietly drives self-funded plan IBNR.
Ortho and MSK Climb Into Stop-Loss High-Cost Top Three
Sun Life's 2026 high-cost claims report puts orthopedic and musculoskeletal conditions into the top tier of stop-loss claims. It is a frequency story, and it reshapes the attachment-point problem for self-funded plans.
FDA Fast-Track Program Raises Gene Therapy Claim Frequency
The FDA's National Priority Voucher pilot has cut some gene-therapy reviews to one or two months, and the reserve variable it moves for self-funded plans is frequency, not severity.
FDA Pediatric Casgevy Approval Tests Stop-Loss Reserves
FDA's July 1 supplemental approval expanded Casgevy to patients aged 2 and older, moving a one-time gene therapy exposure into younger covered dependents and forcing self-funded plans to revisit stop-loss recovery timing.
Sixth Circuit PBM Ruling Tests Pharmacy Claim Reserves
The Sixth Circuit affirmed ERISA preemption of Tennessee PBM network and cost-sharing rules as applied to McKee Foods' self-funded health plan. The reserve issue is whether pharmacy channel controls still support the expected claim ratio and unpaid-claim completion factors.
CMS Drug Model Tests Health Plan Stop-Loss Assumptions
CMS has set a September 10, 2026 state application deadline for the GENEROUS Medicaid drug model. Self-insured employers are outside the model, but its public-payer net-price signal can distort pharmacy trend and stop-loss severity assumptions if plans do not tie benchmarks back to their own PBM contracts.
Cigna Drops GLP-1 for Own Staff as Employer Coverage Plateaus
Cigna will end GLP-1 weight-loss coverage for its 67,700 employees on July 1, the highest-profile signal that employer tolerance for GLP-1 pharmacy costs has peaked, forcing self-insured plan sponsors to model two divergent reserve scenarios.
Stop-Loss Claims Accelerate 9 Points Above Five-Year Trend
Tokio Marine HCC's 2026 Annual Market Report shows January 2025 specific claim trends running 9.2 percentage points above the prior five-year average, pressuring attachment point adequacy for self-insured health plans.
MHPAEA Rule Rewrite by Year-End Leaves Self-Funded Plans Guessing
The tri-agencies will propose a replacement MHPAEA rule by December 31, 2026, leaving self-funded plan sponsors unable to calibrate behavioral health utilization assumptions for plan-year 2027 budgets.
EBRI: Gene Therapy Reaches 9.2 per 100K in Employer Plans
EBRI's first large-scale employer-plan analysis finds cell and gene therapy utilization rose to 9.2 per 100,000 enrollees by 2022, giving self-insured plan sponsors a credible base rate for modeling catastrophic single-claim exposure in their IBNR estimates.
Lockton: Cost Focus Drives Self-Insured Plans to Retain More Risk
Lockton's 2026 survey of 1,705 employers finds cost control has overtaken talent retention as the top benefits priority, pushing self-insured plans toward higher attachment points and thinner stop-loss coverage while claim severity accelerates.
Comorbidities, Not Diagnosis, Push Self-Insured Claims Past $3M
Sun Life's 2026 stop-loss report finds secondary health conditions are the dominant cost driver above $3 million, exposing a structural gap in how self-insured plans model catastrophic claim risk at renewal.
ACA Enrollment Drops 4.8M, Pushing Risk to Self-Funded Plans
KFF projects ACA marketplace effectuated enrollment will fall from 22.3 million to 17.5 million in 2026 as enhanced subsidies expire, shifting risk pool composition and pent-up utilization into self-funded employer health plans.
FTC Consent Decree Opens Spread-Free Option at Express Scripts
A 10-year FTC consent decree requires Express Scripts to offer plan sponsors a standard option that eliminates spread pricing and bases member costs on net drug prices, creating a pharmacy IBNR reset opportunity for self-funded health plans before the January 1, 2027 implementation deadline.
ERISA Fiduciary Wave Reaches Self-Funded Health Plan Sponsors
Four class actions, a Supreme Court pleading shift, and a 12-state inquiry converge to create reservable fiduciary exposure for employers sponsoring self-funded health plans.
Nebraska Starts Medicaid Work Rules as Cost Shift to Plans Begins
Nebraska's May 1 launch of Medicaid work requirements begins a state-by-state coverage contraction that will push hospital cost-shifting and enrollment mix changes directly into self-insured health plan reserves.
Federal Law Now Requires Full PBM Rebate Pass-Through to Plans
The Consolidated Appropriations Act of 2026 mandates 100% rebate pass-through from PBMs to ERISA plan sponsors, rewiring the pharmacy cost structure that self-insured health plans have budgeted around for years.
GLP-1 Cost Surge Exposes Pharmacy and Stop-Loss Planning Gap
Per-member GLP-1 allowed costs surged 840% from 2022 to 2024, but most self-insured employers still manage pharmacy benefits and stop-loss strategy as separate exercises, missing how sustained utilization compounds into aggregate exposure.
DOL Parity Report Flags Self-Funded Plans for NQTL Gaps
The Tri-Agencies' fourth MHPAEA enforcement report documents 15 noncompliance findings and reminds self-funded plans that parity responsibility sits with the plan, not the TPA, raising behavioral health utilization assumptions for benefits directors modeling reserve impact.
$1M+ Claims Hit Half of Self-Insured Plans as Cancer Costs Surge
The 2025 Aegis Risk survey found 49% of self-insured employers now report at least one claimant exceeding $1 million, more than double the prior year, reshaping catastrophic claim frequency assumptions for stop-loss attachment and aggregate corridor calculations.
Gene Therapy's $4M Claims Are Testing Stop-Loss Attachment Points
Single claims of $3M to $4.5M are breaching specific stop-loss thresholds, and rising eligible-patient counts threaten to blow through aggregate corridors for self-insured health plans that set expected claim ratios without a gene therapy loading factor.
Lilly's $149 Oral GLP-1 Pill Forces Self-Insured Plans to Rethink Exclusions
Foundayo's $149 monthly price point collapses the cost barrier that kept oral GLP-1s off most self-insured formularies, forcing immediate revisions to pharmacy PMPM assumptions and stop-loss attachment points.
Medicare GLP-1 Bridge July 1 Pressures Employer Stop-Loss
Medicare's six-month demonstration covering Wegovy and Zepbound for obesity reshapes the expected claim ratio on Rx for self-insured health plans and forces a mid-year look at specific stop-loss attachment adequacy.
DOL PBM Fee Rule Targets Hidden Costs in Self-Insured Plans
A proposed DOL disclosure rule would force pharmacy benefit managers to reveal every dollar of compensation from ERISA self-insured plans, potentially lowering pharmacy reserve assumptions while creating new fiduciary liability exposure.
The Reserving Briefing.
One email a week for self-insureds and captives. Reserving fundamentals, method notes, and commentary on what's actually moving loss development this quarter.